![[Pasted image 20231014232358.png|300]]
# 藥動
## 給藥 Administration
- Rivaroxban  
	- 第一個口服 Factor Xa inhibitor
- Apixaban 
	- 第二個口服 Factor Xa inhibitor
- Edoxaban
	- 快速吸收
	- BA 62%
- Betrixaban 
	- BA 34%
	- 空腹服用
## 分布 Distribution
## 代謝 Metabolism
| Compound   |            |                        |              |                       |
| ---------- | ---------- | ---------------------- | ------------ | --------------------- |
| Rivaroxban | CYP3A4/2J2 | hydroxylation products |              |                       |
| Apixaban   | CYP3A4/3A5 | O-desmethylapixaban    | 無活性代謝物 | 也被CYP1A2, P-gp 代謝 |
| Edoxaban   | P-gp       |                        |              |                       |
| Betrixaban | P-gp代謝 ❌CYP450  | hydrolysis                       |              |                       |

- ![[Pasted image 20231014231405.png|300]]

## 排泄 Excretion
# 應用
# 副作用
- Edoxaban
	- 需劑量調整
		- 低體重
		- 腎功能障礙
		- P-gp inhibitors
# 藥物交互作用
# 解毒劑
- Rivaroxaban & Apixaban
	- Andexanet alfa
# 藥化
## MOA
- 抑制 free and clot-bound form of ==factor Xa==
## SAR
![[Pasted image 20231002212954.png|300]]
- Rivaroxban
	- H bond 重要
	- ==oxazolidine== carbonyl + ==chlorothiophene== carboxamide 結合至 Gly219
	- morpholinone 提高活性
	- 可逆、高選擇性

| Compond    |             |     |
| ---------- | ----------- | --- |
| Rivaroxban | oxazolidine |   Piperidone   |
| Apixaban   | carboxamide |  Piperidone   |
| Edoxaban   | Tetrahydrothiazolopyridine            |     |
| Betrixaban |   Chloropyridine           |     |

